UK markets closed

BetterLife Pharma Inc (NPAU.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.0785-0.0030 (-3.68%)
At close: 08:48PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/01/2024
31/01/2023
31/01/2022
31/01/2021
Total revenue
0
0
0
0
0
Operating expenses
Research development
570.947
570.947
2,677
5,421
284.7
Selling general and administrative
2,639
2,639
6,562
4,531
7,559
Total operating expenses
3,210
3,210
9,257
9,970
7,954
Operating income or loss
-3,210
-3,210
-9,257
-9,970
-7,954
Interest expense
50.897
50.897
67.178
58.345
40.1
Total other income/expenses net
396.326
396.326
-24.236
-740.022
-28,174
Income before tax
-2,899
-2,899
-9,373
-11,993
-36,351
Income tax expense
0
0
0
166.666
0
Income from continuing operations
-2,899
-2,899
-9,373
-12,159
-36,351
Net income
-2,889
-2,889
-9,016
-12,159
-36,351
Net income available to common shareholders
-2,889
-2,889
-9,016
-12,159
-36,351
Basic EPS
-0.02
-0.03
-0.10
-0.16
-1.34
Diluted EPS
-0.02
-0.03
-0.10
-0.16
-1.34
Basic average shares
102,952
109,286
86,561
75,470
27,027
Diluted average shares
102,952
109,286
86,561
75,470
27,027